FDA GFI, ICH Q12: Implementation Considerations for FDA-Regulated Products, DRAFT, 05/21 Anna Sandberg2022-02-04T08:10:03+00:00September 29th, 2021|
FDA GFI, Info to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically-Powered Medical Devices, 11/15 DRAFT 2021-09-22T13:13:31+00:00January 17th, 2020|
FDA GFI, Least Burdensome Provisions: Concept and Principles, 12/17 DRAFT 2020-02-17T15:31:00+00:00January 17th, 2020|
FDA Guideline on Repackaging of Solid Oral Dosage Form Drug Products, Draft, 09/92 2021-09-22T14:07:05+00:00January 17th, 2020|
FDA GFI, Testing and Labeling Medical Devices for Safety in the MR Environment, DRAFT 08/19 Lars-Eric Ellow2020-02-18T11:09:59+00:00December 10th, 2019|